Park Place Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24
Closed -$520 896
2024
Q2
$520 Sell
24
-158
-87% -$3.32K ﹤0.01% 849
2024
Q1
$4.03K Buy
182
+68
+60% +$1.66K ﹤0.01% 755
2023
Q4
$3.14K Buy
114
+7
+7% +$169 ﹤0.01% 759
2023
Q3
$2.39K Hold
107
﹤0.01% 907
2023
Q2
$2.73K Hold
107
﹤0.01% 917
2023
Q1
$2.39K Hold
107
﹤0.01% 933
2022
Q4
$3K Buy
+107
New +$2.49K ﹤0.01% 925

Other funds holding VCYT

Park Place Capital's VCYT Position: Q3 2024 in Review

Park Place Capital sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 24 shares — an estimated $520 sold.

Park Place Capital first reported a position in VCYT in Q4 2022 and held it in 7 quarters. The position peaked at $4.03K in Q1 2024. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.

  • Park Place Capital reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
  • Park Place Capital sold 24 Veracyte shares in Q3 2024, an estimated $520.
  • Park Place Capital first reported a position in Veracyte in Q4 2022 and held it in 7 quarters.
  • Park Place Capital's Veracyte position peaked at $4.03K in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.

Based on Park Place Capital's 13F filing for Q3 2024, filed 8 Oct 2024.